After breaking through the blockbuster sales threshold in 2025, AstraZeneca’s three-in-one inhaler Breztri Aerosphere has passed another crucial milestone as it chips in on the British drugmaker’s goal to reach revenues of $80 billion by 2030.
After breaking through the blockbuster sales threshold in 2025, AstraZeneca’s three-in-one inhaler Breztri Aerosphere has passed another crucial milestone as it chips in on the British drugmaker’s goal to reach revenues of $80 billion by 2030.
After submitting plans to cut 114 jobs tied to its U.S. headquarters in New Jersey in March, Novartis late last month added a handful of additional …
طور باحثون تقنية جديدة تعرف بـ"زراعة القلب الجزئية"، تتيح تغيير صمامات القلب وحدها، مع إمكانية نموها مع الأطفال المولودين بعيوب خلقية.
Thousands of patients will be offered a new injectable form of an immunotherapy drug that takes minutes.
آلام المفاصل شائعة، لكن الخرافات المحيطة بها أكثر شيوعًا لا يزال الكثيرون يعتقدون أن التهاب المفاصل مشكلة تصيب كبار السن فقط.